Jupiter Neurosciences, Inc. (JUNS) stock
JUNSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.52−0.18 (-10.59%)
Close on Nov 17, 2026Market cap $1.17MP/E –Yield –
Jupiter Neurosciences cash
Cash and short-term investments held at the end of each period.
Jupiter Neurosciences's cash was $1.52M at Jun 30, 2026. For fiscal 2025 it was $3.79M, up 0.5% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.79M | +0.5% |
| FY2024 | Dec 31, 2024 | $3.77M | +13136.6% |
| FY2023 | Dec 31, 2023 | $28.48K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.52M | -19.0% |
| Q1 FY2026 | Mar 31, 2026 | $2.36M | -12.7% |
| Q4 FY2025 | Dec 31, 2025 | $3.79M | +0.5% |
| Q3 FY2025 | Sep 30, 2025 | $723.80K | +285985.8% |
| Q2 FY2025 | Jun 30, 2025 | $1.88M | +6495.4% |
| Q1 FY2025 | Mar 31, 2025 | $2.71M | – |
| Q4 FY2024 | Dec 31, 2024 | $3.77M | – |
| Q3 FY2024 | Sep 30, 2024 | $253 | – |
| Q4 FY2023 | Dec 31, 2023 | $28.48K | – |
See a number that looks wrong?